semaglutide for type 2 diabetes Popular Drug Associated with Increased Risk of NAION Oral Semaglutide GLP-1 for Type

Mechanism of Action In a healthy person, incretins such as GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) are released by the intestines after food is ingested

According to the MHRA-approved Summary of Product Characteristics (SmPC), the most commonly reported side effects include nausea, vomiting, diarrhoea, abdominal pain, and constipation

Long-term or unsupervised use is not recommended, as excessive dosing may lead to unknown health effects

Active principle from Moringa oleifera Lam leaves effective against two leukemias and a hepatocarcinoma

Available at: E.P., Youn, H.A., Ginsburg, H.B., Ren, C.J., Fielding, G.A., (2007)

Reuben A, Tillman H, Fontana RJ, Davern T, McGuire B, Stravitz RT, et al